Is Baxter Stock Underperforming the Nasdaq? Baxter International has underperformed the Nasdaq over the past year, and analysts are cautious about the stock’s prospects. Barchart · Sep 21
Cancer Patients Needing Ifosfamide Chemotherapy May Receive an Unapproved Imported Version as the U.S. Shortage Persists An unapproved ifosfamide made for China's market is being imported to ease a U.S. shortage. What cancer patients and caregivers should ask. Medical Daily · Sep 12
Ifosfamide Is Scarce at 94 Percent of Surveyed Cancer Centers, and Every Responding Center Reports a Drug Shortage Every cancer center in a new NCCN survey reports at least one drug shortage, led by ifosfamide. What patients in treatment should ask now. Medical Daily · Sep 11
Two IV Saline Recalls Within Days Cite Iron Oxide and Fiberglass Particles Found Inside Sealed Hospital Bags Baxter and B. Braun recalled lots of 0.9% sodium chloride injection days apart, citing fiberglass and iron oxide particles in solution. Medical Daily · Sep 4
Hospitals Told to Pull IV Saline Bags After Fiberglass and Rust Particles Found in Sterile Fluids Baxter and B. Braun recalled intravenous fluids used in hospitals after fiberglass, iron oxide, and steel particles were found. No injuries were reported. Medical Daily · Sep 2
Oncologists Just Got a Three Tier Rationing Playbook for a Chemotherapy Drug with No Substitute ASCO has directed cancer practices to a federal conservation framework as ifosfamide, a chemotherapy with no direct substitute, runs critically low. Medical Daily · Aug 31
Baxter Recalls Three Intravenous Solutions on the Same Day Over Fiberglass and Stainless Steel Particle Concerns Baxter recalled three IV solutions due to possible fiberglass and stainless steel particles. Here are the lots, the states, and who is affected. Medical Daily · Aug 28
IV Saline Recalled Nationwide After Potential Fibreglass Contamination Raises Risk of Blood Clots and Death Baxter International recalls saline bags in 14 US states after discovering fibreglass particles, posing risks of blood clots and organ damage. Hospitals are urged to stop using affected lots immediately. International Business Times UK · Aug 27
Cancer Practices Report Only Weeks of Ifosfamide on Hand as Oncologists Warn No Substitute Drug Exists ASCO warns some oncology practices have under a few weeks of ifosfamide left, with no direct substitute for the chemotherapy drug. Medical Daily · Aug 27
Baxter Recalls an IV Nutrition Solution After Stainless Steel Particles Turned Up Inside the Sterile Bag Baxter recalled a lot of 70% dextrose injections due to stainless steel particles. Homecare parenteral nutrition patients should be contacted. Medical Daily · Aug 26
Cardboard Found Inside a Sealed Bag of Sterile Antibiotic Prompts a Nationwide Baxter Recall Baxter recalled many cefazolin infusion bags after cardboard was found in the sterile solution. What it means and who was exposed. Medical Daily · Jul 31
Baxter Recalls a Lot of Cefazolin, the Antibiotic Most Often Used to Prevent Surgical Infections Baxter recalled one lot of Cefazolin in Dextrose Injection after cardboard particles were found. Why it matters for surgery patients. Medical Daily · Jul 29
Baxter International's Q2 2026 Earnings: What to Expect Baxter International will release its second-quarter earnings soon, and analysts anticipate a double-digit profit dip. Barchart · Jul 8
Baxter Stock Is Testing a Bottom After Healthcare Sector Decimation Baxter International (BAX) shares are attempting a technical turnaround, breaking a multi-week downtrend that increasingly appears to have bottomed around $16. The stock currently carries an 8% “Sell” technical opinion from Barchart, but that’s down from 88% a week ago and 56% a month ago. Technical indicators show an aggressive... Barchart · May 22
Barchart · Apr 19 Baxter International Earnings Preview: What to Expect Baxter International is set to announce its first-quarter results this month, with analysts predicting a single-digit decline in the company's earnings.
Barchart · Mar 18 How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks? Baxter has notably underperformed the Medical Devices industry over the past year, and analysts are cautious about the stock’s prospects.
Barchart · Jan 30 Are Wall Street Analysts Predicting Baxter International Stock Will Climb or Sink? As Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Barchart · Jan 19 What You Need To Know Ahead of Baxter International's Earnings Release Baxter International is set to announce its fourth-quarter results soon, with analysts predicting a single-digit decline in the company's earnings.
Barchart · Nov 3, 2025 Is Wall Street Bullish or Bearish on Baxter International Stock? As Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Benzinga · Oct 30, 2025 Baxter Trims Annual Outlook Again, Stock Hits 52-Week Baxter International Inc. (NYSE:BAX) stock hit a 52-week low on Thursday, after the company again lowered its 2025 guidance.
Barchart · Sep 19, 2025 Is Baxter International Stock Underperforming the Dow? Baxter International has considerably underperformed the Dow over the past year, and analysts are cautious about the stock’s prospects.
Barchart · Aug 4, 2025 Are Wall Street Analysts Bullish on Baxter International Stock? While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously optimistic about its future potential.
Benzinga · Jul 31, 2025 Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook Baxter International Inc. (NYSE:BAX) is down 19.4% at $22.66 at the last check on Thursday. At around 11 a.m. EST, shares of the medical device company traded at $21.68—just shy of its 52-week low.
Barchart · Jun 20, 2025 Is Baxter International Stock Underperforming the Nasdaq? Baxter International has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Barchart · May 6, 2025 What Are Wall Street Analysts' Target Price for Baxter International Stock? Although Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.